-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the innovative product registration application for the digestive tract vibrating capsule system produced by Shanghai Anhan Medical Technology Co.
, Ltd.
has been reviewed by the State Food and Drug Administration and approved for use in medical institutions under the guidance of qualified physicians
.
According to the list of approved innovative medical device products released by the State Food and Drug Administration, the digestive tract vibration capsule system is the 13th innovative medical device approved this year.
So far, the State Food and Drug Administration has approved a total of 147 innovative medical devices
.
Ankon Medical Digestive Tract Vibrating Capsule System is composed of disposable digestive tract vibrating capsule (referred to as "capsule"), configurator and VCP software (VCP2.
1)
.
According to the data, the product stimulates the colon wall through vibration, promotes colonic peristalsis, and provides a new treatment method for adult functional chronic transit constipation with poor drug treatment effect
.
The product has two innovations: the capsule has the ability to detect acceleration, which can be activated by monitoring the change of the acceleration value; the product belongs to non-drug treatment and can be used as another treatment plan for functional constipation
.
It is understood that in recent years, the state has successively issued many policies, all of which are vigorously supporting the development of the medical device industry
.
China's medical device industry has entered a golden stage of development
.
In addition to the approval of the above-mentioned products, the author was informed that on March 1, the Medical Device Technology Review Center of the State Drug Administration also reviewed and approved 6 products to enter the innovation approval channel, one of which is Shenzhen Mindray Biomedical Electronics Co.
, Ltd.
Automatic peripheral blood cell morphology analyzer, transcatheter aortic valve system from Peijia Medical Technology (Suzhou) Co.
, Ltd.
, and anti-CD19-chimeric antigen receptor T cell detection kit from Shanghai Xingwan Biotechnology Co.
, Ltd.
cytometry-PE), Prostate Lifting System of MicroPort Youtong Medical Technology (Jiaxing) Co.
, Ltd.
, Bioabsorbable Peripheral Vascular Drug Eluting Stent System of Beijing Amat Medical Devices Co.
, Ltd.
, Hangzhou Batai Medical Devices Ltd.
's Paclitaxel Drug-Coated Peripheral Balloon Dilation Catheter
.
Since 2022, 7 product projects have passed the special review application for innovative medical devices and officially entered the green approval process
.
In addition, according to the list of approved innovative medical device products released by the State Food and Drug Administration, up to now, China has approved 147 innovative medical devices
.
Among them, in 2021, the State Food and Drug Administration approved a total of 35 innovative medical device products, an increase of 35% year-on-year and a record high
.
In the first two months of 2022, the State Food and Drug Administration has approved 13 innovative medical device products
.
According to the data, from 2014 to 2021, the State Food and Drug Administration approved a total of 134 innovative medical devices, domestic innovative medical devices involved 104 companies in 14 provinces, and imported innovative medical devices involved 5 companies in 2 countries
.
Analysts said that during the "14th Five-Year Plan" period, the development of medical devices has ushered in huge opportunities
.
Adhering to technological innovation will enable the medical device industry to seize the opportunity and embark on the fast track of rapid development
.
And with the efforts of more and more medical device companies, China's medical devices will gradually become more mobile, portable and intelligent
.
Looking at the domestic market, as of 2020, the scale of China's medical device market has increased by 15.
5% year-on-year to about 811.
8 billion yuan, which is close to four times the growth rate of global medical devices.
billion
.
Looking forward to the future, driven by policies, innovation capability will become the long-term core competitiveness for medical device companies to stand out and grow.
Get more opportunities
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
, Ltd.
has been reviewed by the State Food and Drug Administration and approved for use in medical institutions under the guidance of qualified physicians
.
According to the list of approved innovative medical device products released by the State Food and Drug Administration, the digestive tract vibration capsule system is the 13th innovative medical device approved this year.
So far, the State Food and Drug Administration has approved a total of 147 innovative medical devices
.
Ankon Medical Digestive Tract Vibrating Capsule System is composed of disposable digestive tract vibrating capsule (referred to as "capsule"), configurator and VCP software (VCP2.
1)
.
According to the data, the product stimulates the colon wall through vibration, promotes colonic peristalsis, and provides a new treatment method for adult functional chronic transit constipation with poor drug treatment effect
.
The product has two innovations: the capsule has the ability to detect acceleration, which can be activated by monitoring the change of the acceleration value; the product belongs to non-drug treatment and can be used as another treatment plan for functional constipation
.
It is understood that in recent years, the state has successively issued many policies, all of which are vigorously supporting the development of the medical device industry
.
China's medical device industry has entered a golden stage of development
.
In addition to the approval of the above-mentioned products, the author was informed that on March 1, the Medical Device Technology Review Center of the State Drug Administration also reviewed and approved 6 products to enter the innovation approval channel, one of which is Shenzhen Mindray Biomedical Electronics Co.
, Ltd.
Automatic peripheral blood cell morphology analyzer, transcatheter aortic valve system from Peijia Medical Technology (Suzhou) Co.
, Ltd.
, and anti-CD19-chimeric antigen receptor T cell detection kit from Shanghai Xingwan Biotechnology Co.
, Ltd.
cytometry-PE), Prostate Lifting System of MicroPort Youtong Medical Technology (Jiaxing) Co.
, Ltd.
, Bioabsorbable Peripheral Vascular Drug Eluting Stent System of Beijing Amat Medical Devices Co.
, Ltd.
, Hangzhou Batai Medical Devices Ltd.
's Paclitaxel Drug-Coated Peripheral Balloon Dilation Catheter
.
Since 2022, 7 product projects have passed the special review application for innovative medical devices and officially entered the green approval process
.
In addition, according to the list of approved innovative medical device products released by the State Food and Drug Administration, up to now, China has approved 147 innovative medical devices
.
Among them, in 2021, the State Food and Drug Administration approved a total of 35 innovative medical device products, an increase of 35% year-on-year and a record high
.
In the first two months of 2022, the State Food and Drug Administration has approved 13 innovative medical device products
.
According to the data, from 2014 to 2021, the State Food and Drug Administration approved a total of 134 innovative medical devices, domestic innovative medical devices involved 104 companies in 14 provinces, and imported innovative medical devices involved 5 companies in 2 countries
.
Analysts said that during the "14th Five-Year Plan" period, the development of medical devices has ushered in huge opportunities
.
Adhering to technological innovation will enable the medical device industry to seize the opportunity and embark on the fast track of rapid development
.
And with the efforts of more and more medical device companies, China's medical devices will gradually become more mobile, portable and intelligent
.
Looking at the domestic market, as of 2020, the scale of China's medical device market has increased by 15.
5% year-on-year to about 811.
8 billion yuan, which is close to four times the growth rate of global medical devices.
billion
.
Looking forward to the future, driven by policies, innovation capability will become the long-term core competitiveness for medical device companies to stand out and grow.
Get more opportunities
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
